Rhode Island Hospital recruiting Alzheimer’s patients for TANGO study

RHODE ISLAND HOSPITAL researchers are investigating whether a new drug, BIIB092, can prevent damaging tau proteins from spreading through the brains of people with Alzheimer’s disease. / COURTESY LIFESPAN CORP.
PROVIDENCE – Rhode Island Hospital Alzheimer’s Disease and Memory Disorders Center researchers are recruiting volunteers for TANGO, a national clinical trial evaluating whether a new drug using antibodies to target tau protein in the brains of people with the disease is an effective treatment. The trial is sponsored by Biogen, based in Massachusetts. The drug,…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display